Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Inflammatory Bowel Disease
NCT02460705Phase 1Completed
- Sponsor
- University of California, San Francisco
- Start
- Jun 2015
- Primary completion
- Dec 2016
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of fecal microbiome transplant in ulcerative colitis (UC), sponsored by University of California, San Francisco. Primary endpoint: Clinical improvement of IBD at 4 weeks. Started Jun 2015; status: completed.
02
Drugs
fecal microbiome transplant
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT02460705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02460705.